MariMed Announces Strong Q1 2019 Earnings, Revenue and Adjusted EBITDA Jump 69% and 76% Respectively
Significant improvement in operating performance – Revenue up 69%; Adjusted EBITDA up 76% Planned consolidation of cannabis operations under MariMed banner advancing on schedule The launch of MariMed Hemp operations including the development of CBD brands and products Conversion of debt investment... read more →